Email this article Combined treatment of metastatic renal cell carcinoma in spine
- Authors: Shirokorad V.I.1, Kostritskii S.V.1, Zaborovskiy N.S.2, Ptashnikov D.A.2
-
Affiliations:
- Moscow City Cancer Hospital No 62, Moscow Healthcare Department
- R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics
- Issue: Vol 13, No 2 (2017)
- Pages: 43-48
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
- Published: 30.06.2017
- URL: https://oncourology.abvpress.ru/oncur/article/view/637
- DOI: https://doi.org/10.17650/1726-9776-2017-13-2-43-48
- ID: 637
Cite item
Full Text
Abstract
This study is a retrospective analysis of the combined treatment of patients with metastatic renal cell carcinoma who had undergone spinal surgery. Objective: to evaluate the effect of the type of surgery on the spine, as well as targeted therapy on outcomes, quality of life and long-term outcomes of patients with mRCC in the spine. According to our data the survival of patients treated with targeted therapy was significantly higher than in patients without it. The use of targeted therapy in conjunction with surgery and sometimes teletherapy (DLT), increases survival and improves quality of life of patients with mRCC in the spine.
About the authors
V. I. Shirokorad
Moscow City Cancer Hospital No 62, Moscow Healthcare Department27 Istra Settlement, Moscow Region 143423 Russian Federation
S. V. Kostritskii
Moscow City Cancer Hospital No 62, Moscow Healthcare Department
Author for correspondence.
Email: Stas.medic@bk.ru
27 Istra Settlement, Moscow Region 143423 Russian Federation
N. S. Zaborovskiy
R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics8 Acad. Baykova St., Saint Petersburg 195427 Russian Federation
D. A. Ptashnikov
R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics8 Acad. Baykova St., Saint Petersburg 195427
References
Supplementary files
